Comparative analysis of tumor and mesorectum radiomics in predicting neoadjuvant chemoradiotherapy response in locally advanced rectal cancer.
Journal:
Diagnostic and interventional radiology (Ankara, Turkey)
Published Date:
Aug 12, 2025
Abstract
PURPOSE: Neoadjuvant chemoradiotherapy (CRT) is known to increase sphincter preservation rates and decrease the risk of postoperative recurrence in patients with locally advanced rectal tumors. However, the response to CRT in patients with locally advanced rectal cancer (LARC) varies significantly. The objective of this study was to compare the performance of models based on radiomics features of the tumor alone, the mesorectum alone, and a combination of both in predicting tumor response to neoadjuvant CRT in LARC.
Authors
Keywords
No keywords available for this article.